Elevate Health vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Elevate Health overall, scoring 7.7/10 vs 7.2/10. Elevate Health is more affordable at $233/mo vs $299/mo. Choose Elevate Health for users who want financing options and free lab work with thei. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Elevate Health and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Elevate Health
#34 of 40Affordable compounded GLP-1 provider with financing options and complimentary lab work for qualifying patients.
Visit Elevate HealthMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Elevate Health | MEDVi |
|---|---|---|
| Our Score | 7.2/10 | 7.7/10 |
| Starting Price | $233/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want financing options and free lab work with their GLP-1 program | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #34 | #21 |
Pros & Cons Compared
Elevate Health
Pros
- +Oral semaglutide from $114/mo — one of the lowest prices for any form of semaglutide in the market
- +Free blood work included with all GLP-1 programs for baseline health assessment and monitoring
- +Buy-now-pay-later financing via Affirm, Klarna, and Afterpay — removes the upfront cost barrier
- +Medications sourced from FDA-registered 503B outsourcing facilities — stricter oversight than standard compounding
Cons
- −Promo-dependent pricing — standard tirzepatide is $449/mo without discount, nearly double the promo price
- −Select state availability only — not available nationwide
- −Trustpilot rating flagged for potential review solicitation — verify independently
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Elevate Health with a score of 7.7/10 vs 7.2/10. If budget is your priority, Elevate Health starts at $233/mo compared to MEDVi's $299/mo. Choose Elevate Health if you want: users who want financing options and free lab work with their glp-1 program. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.